CLN3 protein is targeted to neuronal synapses but excluded from synaptic vesicles: new clues to Batten disease - PubMed (original) (raw)
Comparative Study
. 2001 Sep 15;10(19):2123-31.
doi: 10.1093/hmg/10.19.2123.
Affiliations
- PMID: 11590129
- DOI: 10.1093/hmg/10.19.2123
Comparative Study
CLN3 protein is targeted to neuronal synapses but excluded from synaptic vesicles: new clues to Batten disease
K Luiro et al. Hum Mol Genet. 2001.
Abstract
Batten disease (juvenile neuronal ceroid lipofuscinosis, JNCL), the most common neurodegenerative disease of childhood, is caused by mutations in the CLN3 gene encoding a putative transmembrane protein. The function of CLN3 is currently unknown but it has been shown to localize in the endosomal/lysosomal compartments of non-neuronal cells. In addition, several other intracellular localizations have been proposed and the controversy of the reports suggests that CLN3 may have different intracellular localization in different cell types. Batten disease severely affects neuronal cells but leaves other organs clinically unaffected, and thus it is of utmost importance to approach the disease mechanism by studying the expression and localization of CLN3 in the brain and neuronal cells. We have analysed here CLN3 in the mouse brain using in situ hybridization, immunohistochemical staining and western blot analysis of subcellular fractions. As visual deterioration is the hallmark of Batten disease we have set up primary retinal cultures from the mouse and analysed both endogenous mouse CLN3 and Semliki Forest virus-mediated human CLN3 localization using immunofluorescence staining and confocal microscopy. We demonstrate that CLN3 is abundantly expressed in neuronal cells, especially in the cortex, hippocampus and cerebellum of the adult mouse brain. Furthermore, our results indicate that in neurons CLN3 is not solely a lysosomal protein. It is localized in the synaptosomes but, interestingly, is not targeted to the synaptic vesicles. The novel localization of CLN3 directs attention towards molecular alterations at the synapses. This should yield important clues about the mechanisms of neurodegeneration in Batten disease.
Similar articles
- Current Insights in Elucidation of Possible Molecular Mechanisms of the Juvenile Form of Batten Disease.
Shematorova EK, Shpakovski GV. Shematorova EK, et al. Int J Mol Sci. 2020 Oct 29;21(21):8055. doi: 10.3390/ijms21218055. Int J Mol Sci. 2020. PMID: 33137890 Free PMC article. Review. - Biosynthesis and intracellular targeting of the CLN3 protein defective in Batten disease.
Järvelä I, Sainio M, Rantamäki T, Olkkonen VM, Carpén O, Peltonen L, Jalanko A. Järvelä I, et al. Hum Mol Genet. 1998 Jan;7(1):85-90. doi: 10.1093/hmg/7.1.85. Hum Mol Genet. 1998. PMID: 9384607 - Defective intracellular transport of CLN3 is the molecular basis of Batten disease (JNCL).
Järvelä I, Lehtovirta M, Tikkanen R, Kyttälä A, Jalanko A. Järvelä I, et al. Hum Mol Genet. 1999 Jun;8(6):1091-8. doi: 10.1093/hmg/8.6.1091. Hum Mol Genet. 1999. PMID: 10332042 - Revisiting the neuronal localization and trafficking of CLN3 in juvenile neuronal ceroid lipofuscinosis.
Oetjen S, Kuhl D, Hermey G. Oetjen S, et al. J Neurochem. 2016 Nov;139(3):456-470. doi: 10.1111/jnc.13744. Epub 2016 Sep 9. J Neurochem. 2016. PMID: 27453211
Cited by
- Early postnatal administration of an AAV9 gene therapy is safe and efficacious in CLN3 disease.
Johnson TB, Brudvig JJ, Likhite S, Pratt MA, White KA, Cain JT, Booth CD, Timm DJ, Davis SS, Meyerink B, Pineda R, Dennys-Rivers C, Kaspar BK, Meyer K, Weimer JM. Johnson TB, et al. Front Genet. 2023 Mar 24;14:1118649. doi: 10.3389/fgene.2023.1118649. eCollection 2023. Front Genet. 2023. PMID: 37035740 Free PMC article. - Mass spectrometry-based proteomics in neurodegenerative lysosomal storage disorders.
Li W, Cologna SM. Li W, et al. Mol Omics. 2022 May 11;18(4):256-278. doi: 10.1039/d2mo00004k. Mol Omics. 2022. PMID: 35343995 Free PMC article. Review. - CLN3, at the crossroads of endocytic trafficking.
Cotman SL, Lefrancois S. Cotman SL, et al. Neurosci Lett. 2021 Sep 25;762:136117. doi: 10.1016/j.neulet.2021.136117. Epub 2021 Jul 16. Neurosci Lett. 2021. PMID: 34274435 Free PMC article. - Gene correction of the CLN3 c.175G>A variant in patient-derived induced pluripotent stem cells prevents pathological changes in retinal organoids.
Zhang X, Zhang D, Thompson JA, Chen SC, Huang Z, Jennings L, McLaren TL, Lamey TM, De Roach JN, Chen FK, McLenachan S. Zhang X, et al. Mol Genet Genomic Med. 2021 Mar;9(3):e1601. doi: 10.1002/mgg3.1601. Epub 2021 Jan 26. Mol Genet Genomic Med. 2021. PMID: 33497524 Free PMC article. - Current Insights in Elucidation of Possible Molecular Mechanisms of the Juvenile Form of Batten Disease.
Shematorova EK, Shpakovski GV. Shematorova EK, et al. Int J Mol Sci. 2020 Oct 29;21(21):8055. doi: 10.3390/ijms21218055. Int J Mol Sci. 2020. PMID: 33137890 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials